Signadori Bio

Seed
signadoribio.com Biotech & Healthcare Paris, France
Total Funding $12.9M
Latest Round $12.9M Seed
Last Announced May 6, 2026
Investors Undisclosed
Decision Makers 2 Verified

About Signadori Bio

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Paris, France
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website signadoribio.com
Domain Registered Date Mar 6, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $12,937,100 · Seed

    Ventureburn

  2. Milestone

    Website domain registered

    signadoribio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Signadori Bio.

Funding History

1 Round
Seed · May 6, 2026
$12,937,100 Ventureburn

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts